Michael Nacol
Internal Medicine · Georgetown, TXNPI 1114915030
Payments from drug & device makers
Across 473 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$788
- AstraZeneca$780
- Novo Nordisk$773
- Boehringer Ingelheim$665
- Lilly USA, LLC$664
- Amgen$595
- plus $3K from 34 others
What the payments were for
- Food & beverage$7,54399%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 47 | $788 |
| AstraZeneca | 43 | $780 |
| Novo Nordisk | 56 | $773 |
| Boehringer Ingelheim | 42 | $665 |
| Lilly USA, LLC | 51 | $664 |
| Amgen | 41 | $595 |
| AbbVie(2 entities) | 28 | $513 |
| Bayer | 13 | $362 |
| Pfizer | 14 | $275 |
| Mylan Specialty L.p. | 13 | $208 |
| Johnson & Johnson | 13 | $202 |
| Radius Health, Inc. | 12 | $188 |
| Abbott | 10 | $177 |
| Astellas Pharma US Inc | 9 | $143 |
| Esperion Therapeutics, Inc. | 3 | $131 |
| Novartis | 8 | $129 |
| Medtronic(2 entities) | 7 | $128 |
| Merck | 17 | $112 |
| Shire North American Group Inc | 5 | $110 |
| Sanofi-aventis U.S. LLC | 6 | $86 |
| Alk-abello, Inc | 5 | $72 |
| Amarin Pharma, Inc. | 4 | $71 |
| Supernus Pharmaceuticals, Inc. | 4 | $58 |
| IBSA Pharma Inc. | 3 | $42 |
| Corcept Therapeutics | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Antares Pharma, Inc. | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Halozyme Inc | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Stryker | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $14 |
| Medicure Pharma Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Mannkind Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$139
How this compares
$7,600 in reported general payments places this provider in the 90th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 52 | $65,974 |
| OzempicSemaglutide | 21 | $33,954 |
| FarxigaDapagliflozin Propanediol | 14 | $16,335 |
| SynthroidLevothyroxine Sodium | 28 | $1,998 |
| Levothyroxine Sodium | 145 | $1,655 |
| Ezetimibe | 36 | $1,130 |
| Rosuvastatin Calcium | 74 | $1,109 |
| Atorvastatin Calcium | 160 | $1,063 |
| Telmisartan | 29 | $920 |
| Gabapentin | 44 | $843 |
| Irbesartan | 41 | $827 |
| Finasteride | 55 | $745 |
| Potassium Chloride | 28 | $710 |
| Tamsulosin Hcl | 42 | $672 |
| Bupropion XlBupropion Hcl | 21 | $654 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $665 | $65,97452 claims |
| Novo NordiskOzempic | $773 | $33,95421 claims |
| AstraZenecaFarxiga | $780 | $16,33514 claims |
| AbbVieSynthroid | $513 | $1,99828 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Georgetown
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.